Phenergan and Mycelex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenergan (promethazine hydrochloride) and Mycelex (clotrimazole). Common drug interactions include anxiety among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Phenergan and Mycelex. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.

What is Mycelex?

Mycelex has active ingredients of clotrimazole. eHealthMe is studying from 1,876 Mycelex users. Check the latest studies of Mycelex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

100 people who take Phenergan and Mycelex together, and have interactions are studied.

Phenergan and Mycelex drug interactions.

What are the common drug interactions of Phenergan and Mycelex, by gender? *:

female:

Anxiety
Diarrhoea
Injury
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Anaemia (lack of blood)
Metastases to bone (cancer spreads to bone)
Physical disability
Cough
Fall
Osteonecrosis of jaw (death of bone of jaw)

male:

Anxiety
Pain
Anaemia (lack of blood)
Depression
Dizziness
Dyspnoea (difficult or laboured respiration)
Abdominal pain
Chest pain
Confusional state
Osteoarthritis (a joint disease caused by cartilage loss in a joint)

What are the common drug interactions of Phenergan and Mycelex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Activated partial thromboplastin time prolonged
Blood fibrinogen increased
Haematocrit increased
Haemoglobin decreased
Heart rate increased
Hyperglycaemia (high blood sugar)
Pelvic pain
Post procedural complication
Renal arteriosclerosis (a thickening and hardening of arteries of kidney)

30-39:

Dehydration (dryness resulting from the removal of water)
Anaemia (lack of blood)
Renal failure acute (rapid kidney dysfunction)
Abdominal pain
Activated partial thromboplastin time prolonged
Arthralgia (joint pain)
Asthma
Back pain
Blood fibrinogen increased
Blood pressure diastolic decreased

40-49:

Anxiety
Pain
Dehydration (dryness resulting from the removal of water)
Pneumonia
Dizziness
Abdominal pain
Chest pain
Dyspnoea (difficult or laboured respiration)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Depression

50-59:

Dehydration (dryness resulting from the removal of water)
Metastases to bone (cancer spreads to bone)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteoporosis (bones weak and more likely to break)
Sinusitis (inflammation of sinus)
Diarrhoea
Hypotension (abnormally low blood pressure)
Rib fracture
Fall
Osteonecrosis of jaw (death of bone of jaw)

60+:

Chest pain
Fatigue (feeling of tiredness)
Thrombocytopenia (decrease of platelets in blood)
Abdominal pain upper
Anxiety
Arteriosclerosis (thickening and hardening of arteries)
Back pain
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Colitis (inflammation of colon)
Coma (state of unconsciousness lasting more than six hours)

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 14 people, 14.00%
Pain: 13 people, 13.00%
Multiple Myeloma (cancer of the plasma cells): 8 people, 8.00%
Stress And Anxiety: 7 people, 7.00%
Insomnia (sleeplessness): 6 people, 6.00%
Constipation: 5 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Phenergan and Mycelex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously